SCHEMBL17447201

SCHEMBL17447201

COC(=O)C=Cc1cccn1C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
TYR P14679 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
BCHE P06276 1/20 0.38
NR1H4 Q96RI1 3/20 0.37
KDM1A O60341 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
TTR P02766 1/20 0.36
APP P05067 1/20 0.36
ALDH1A1 P00352 3/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 2/20 0.35
KMT2A Q03164 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16052550 0.81 CA12 (0.44) CA12CA1CA2TYRCA7
SCHEMBL17439361 0.81 CA12 (0.44) CA12CA1CA2TYRCA7
SCHEMBL1960653 0.79 HSP90AA1 (0.44) HSP90AA1HSP90AB1BCHEALDH1A1CYP1A2
SCHEMBL10541179 0.79 CYP1B1 (0.46) CA1CA2ALDH1A1MAPTKDM4E
SCHEMBL10541189 0.79 CYP1B1 (0.46) CA1CA2ALDH1A1MAPTKDM4E
SCHEMBL28274140 0.79 BCHE (0.41) HSP90AA1HSP90AB1BCHEALDH1A1KMT2A
SCHEMBL10541950 0.78 ALDH1A1 (0.47) HSP90AA1HSP90AB1BCHEHDAC8HDAC6
SCHEMBL10541945 0.78 ALDH1A1 (0.47) HSP90AA1HSP90AB1BCHEHDAC8HDAC6
SCHEMBL19128661 0.78 HSP90AA1 (0.43) HSP90AA1HSP90AB1BCHEALDH1A1MAPT
SCHEMBL14164203 0.75 NR1H2 (0.47) HSP90AA1HSP90AB1BCHEHDAC6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160016860-A1 METHODS FOR PHOSPHINE OXIDE REDUCTION IN CATALYTIC WITTIG REACTIONS DUBLIN CITY UNIVERSITY (IE) 2016-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160016860-A1 METHODS FOR PHOSPHINE OXIDE REDUCTION IN CATALYTIC WITTIG REACTIONS DCXR, TECR, PWWP2B HSP90AA1 3527/4885HSP90AB1 3585/4885CA12 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.